126 related articles for article (PubMed ID: 2890791)
1. [Treatment with betaxolol and placebo eyedrops in patients with glaucoma and reactive airway diseases].
Bleckmann H; Dorow P
Klin Monbl Augenheilkd; 1987 Sep; 191(3):199-202. PubMed ID: 2890791
[TBL] [Abstract][Full Text] [Related]
2. [Locally applied cardioselective beta blocker and histamine provocation in patients with obstructive airway disease].
Bleckmann H; Dorow P
Fortschr Ophthalmol; 1987; 84(4):346-9. PubMed ID: 2889654
[No Abstract] [Full Text] [Related]
3. Tolerability of timolol and betaxolol in patients with chronic open-angle glaucoma.
Kendall K; Mundorf T; Nardin G; Zimmerman TJ; Hesse R; Lavin P
Clin Ther; 1987; 9(6):651-5. PubMed ID: 2894245
[TBL] [Abstract][Full Text] [Related]
4. Comparison of ophthalmic beta-blocking agents.
Lesar TS
Clin Pharm; 1987 Jun; 6(6):451-63. PubMed ID: 2891463
[TBL] [Abstract][Full Text] [Related]
5. [Timolol, betaxolol and befunolol in the treatment of glaucoma. Study of their bronchopulmonary effects].
Pecori-Giraldi J; Collini S; Planner-Terzaghi A; Arrico L; Grechi G
Fortschr Ophthalmol; 1988; 85(3):235-8. PubMed ID: 2905321
[No Abstract] [Full Text] [Related]
6. [Clinical evaluation of betaxolol in ophthalmic suspension with or without preservative agent in patients with glaucoma or ocular hypertension].
Denis P; Demailly P; Saraux H
J Fr Ophtalmol; 1993; 16(5):297-303. PubMed ID: 8331248
[TBL] [Abstract][Full Text] [Related]
7. A 6-week, double-masked, parallel-group study of the efficacy and safety of travoprost 0.004% compared with latanoprost 0:005%/timolol 0.5% in patients with primary open-angle glaucoma or ocular hypertension.
Franks WA; Renard JP; Cunliffe IA; Rojanapongpun P
Clin Ther; 2006 Mar; 28(3):332-9. PubMed ID: 16750448
[TBL] [Abstract][Full Text] [Related]
8. A 12-month, randomized, double-masked study comparing latanoprost with timolol in pigmentary glaucoma.
Mastropasqua L; Carpineto P; Ciancaglini M; Gallenga PE
Ophthalmology; 1999 Mar; 106(3):550-5. PubMed ID: 10080213
[TBL] [Abstract][Full Text] [Related]
9. Ocular hypotensive efficacy and safety of a combined formulation of betaxolol and pilocarpine.
Robin AL
Trans Am Ophthalmol Soc; 1996; 94():89-101; discussion 101-3. PubMed ID: 8981691
[TBL] [Abstract][Full Text] [Related]
10. A comparison of betaxolol and timolol in open angle glaucoma and ocular hypertension.
Feghali JG; Kaufman PL; Radius RL; Mandell AI
Acta Ophthalmol (Copenh); 1988 Apr; 66(2):180-6. PubMed ID: 2898859
[TBL] [Abstract][Full Text] [Related]
11. The effects of betaxolol hydrochloride ophthalmic solution on intraocular pressures during transient microgravity.
Pattinson TJ; Gibson CR; Manuel FK; Bishop SL; March WF
Aviat Space Environ Med; 1999 Oct; 70(10):1012-7. PubMed ID: 10519481
[TBL] [Abstract][Full Text] [Related]
12. [Comparison of the effect of a selective and a nonselective beta receptor blocker on the ischemic ST segment, lung function and stress-induced decrease in blood glucose].
Brügmann U; Blasini R
Herz; 1986 Feb; 11(1):55-61. PubMed ID: 2870014
[TBL] [Abstract][Full Text] [Related]
13. Two new beta-blockers for glaucoma.
Med Lett Drugs Ther; 1986 Apr; 28(712):45-6. PubMed ID: 2870417
[No Abstract] [Full Text] [Related]
14. Short-term tolerability of once-daily timolol hemihydrate 0.5%, timolol maleate in sorbate 0.5%, and generic timolol maleate gel-forming solution 0.5% in glaucoma and/or ocular hypertension: a prospective, randomized, double-masked, active-controlled, three-period crossover pilot study.
Sonty S; Mundorf TK; Stewart JA; Stewart WC
Clin Ther; 2009 Oct; 31(10):2063-71. PubMed ID: 19922877
[TBL] [Abstract][Full Text] [Related]
15. Beta adrenergic blocking agents for open-angle glaucoma.
Lee ME
J Am Optom Assoc; 1988 Jul; 59(7):567-71. PubMed ID: 2900260
[TBL] [Abstract][Full Text] [Related]
16. Intraocular pressure-lowering effects of latanoprost monotherapy versus latanoprost or pilocarpine in combination with timolol: a randomized, observer-masked multicenter study in patients with open-angle glaucoma. Italian Latanoprost Study Group.
Bucci MG
J Glaucoma; 1999 Feb; 8(1):24-30. PubMed ID: 10084271
[TBL] [Abstract][Full Text] [Related]
17. [Therapeutic consequences of glaucoma treatment with different beta blockers in patients with obstructive respiratory tract diseases].
Bleckmann H; Dorow P
Klin Monbl Augenheilkd; 1986 Jun; 188(6):568-72. PubMed ID: 2876127
[TBL] [Abstract][Full Text] [Related]
18. [Efficacy and safety of long-acting carteolol 1% once daily. A double-masked, randomized study].
Trinquand C; Romanet JP; Nordmann JP; Allaire C;
J Fr Ophtalmol; 2003 Feb; 26(2):131-6. PubMed ID: 12660585
[TBL] [Abstract][Full Text] [Related]
19. Effect of treatment by medicine or surgery on intraocular pressure and pulsatile ocular blood flow in normal-pressure glaucoma.
Poinoosawmy D; Indar A; Bunce C; Garway-Heath DF; Hitchings RA
Graefes Arch Clin Exp Ophthalmol; 2002 Sep; 240(9):721-6. PubMed ID: 12271368
[TBL] [Abstract][Full Text] [Related]
20. Betaxolol eye drops as a safe medication to lower intraocular pressure.
Brooks AM; Gillies WE; West RH
Aust N Z J Ophthalmol; 1987 May; 15(2):125-9. PubMed ID: 2887181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
